Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Susanne Martina Eschmann

Department of Nuclear Medicine

University of Tübingen

Otfried-Mueller-Strasse 14

72076

Germany

[email]@med.uni-tuebingen.de

Name/email consistency: high

[Claim this account]

Affiliations

Department of Nuclear Medicine, University of Tübingen, Otfried-Mueller-Strasse 14, 72076, Germany. 2002 - 2007
University of Tuebingen, Department of Nuclear Medicine, Germany. 2006

References

18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer. Eschmann, S.M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Budach, W., Langen, H.J., Bares, R. Eur. J. Nucl. Med. Mol. Imaging (2007) [Pubmed]
Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors. Eschmann, S.M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Scheiderbauer, J., Budach, W., Kotzerke, J., Bares, R. Eur. J. Nucl. Med. Mol. Imaging (2007) [Pubmed]
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer. Eschmann, S.M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Budach, W., Dittmann, H., Langen, H.J., Bares, R. Lung. Cancer (2007) [Pubmed]
Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study. Eschmann, S.M., Thelen, M.H., Dittmann, H., Bares, R. Exp. Clin. Endocrinol. Diabetes (2006) [Pubmed]
Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?. Eschmann, S.M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Budach, W., Scheiderbauer, J., Machulla, H.J., Dittmann, H., Vonthein, R., Bares, R. Eur. J. Nucl. Med. Mol. Imaging (2006) [Pubmed]
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. Eschmann, S.M., Paulsen, F., Reimold, M., Dittmann, H., Welz, S., Reischl, G., Machulla, H.J., Bares, R. J. Nucl. Med. (2005) [Pubmed]
The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer. Eschmann, S.M., Bitzer, M., Paulsen, F., Friedel, G., Besenfelder, H., Horger, M., Reimold, M., Dittmann, H., Pfannenberg, A.C., Bares, R. Nucl. Med. Commun (2004) [Pubmed]
Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eschmann, S.M., Reischl, G., Bilger, K., Kupferschläger, J., Thelen, M.H., Dohmen, B.M., Besenfelder, H., Bares, R. Eur. J. Nucl. Med. Mol. Imaging (2002) [Pubmed]
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. Eschmann, S.M., Friedel, G., Paulsen, F., Budach, W., Harer-Mouline, C., Dohmen, B.M., Bares, R. Eur. J. Nucl. Med. Mol. Imaging (2002) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.